Engagement/NN
of/IN
the/DT
Lewis/NN
X/NN
antigen/NN
(/(
CD15/NN
)/)
results/VBZ
in/IN
monocyte/NN
activation/NN
./.

We/PRP
previously/RB
reported/VBD
that/IN
monocyte/NN
adhesion/NN
to/TO
tumor/NN
necrosis/NN
factor-alpha/NN
(/(
TNF-alpha/NN
)/)
-treated/JJ
endothelial/JJ
cells/NNS
increased/VBD
expression/NN
of/IN
tissue/NN
factor/NN
and/CC
CD36/NN
on/IN
monocytes/NNS
./.
=====
Using/VBG
immunological/JJ
cross-linking/NN
to/TO
mimic/VB
receptor/NN
engagement/NN
by/IN
natural/JJ
ligands/NNS
,/,
we/PRP
now/RB
show/VBP
that/IN
CD15/NN
(/(
Lewis/NN
X/NN
)/)
,/,
a/DT
monocyte/NN
counter-receptor/NN
for/IN
endothelial/JJ
selectins/NNS
may/MD
participate/VB
in/IN
this/DT
response/NN
./.
=====
We/PRP
used/VBD
cytokine/NN
production/NN
as/IN
a/DT
readout/NN
for/IN
monocyte/NN
activation/NN
and/CC
found/VBD
that/IN
CD15/NN
cross-linking/NN
induced/VBD
TNF-alpha/NN
release/NN
from/IN
peripheral/JJ
blood/NN
monocytes/NNS
and/CC
cells/NNS
from/IN
the/DT
monocytic/JJ
cell/NN
line/NN
MM6/NN
./.
=====
Quantitative/JJ
reverse/JJ
transcriptase-polymerase/JJ
chain/NN
reaction/NN
(/(
RT-PCR/NN
)/)
showed/VBD
an/DT
increase/NN
in/IN
steady-state/JJ
TNF-alpha/NN
mRNA/NN
after/IN
3/CD
to/TO
4/CD
hours/NNS
of/IN
cross-linking/NN
./.
=====
CD15/NN
cross-linking/NN
also/RB
concomitantly/RB
increased/VBD
interleukin-1/NN
beta/NN
(/(
IL-1/NN
beta/NN
)/)
mRNA/NN
,/,
while/IN
no/DT
apparent/JJ
change/NN
was/VBD
observed/VBN
in/IN
the/DT
levels/NNS
of/IN
beta-actin/NN
mRNA/NN
,/,
indicating/VBG
specificity/NN
./.
=====
To/TO
examine/VB
transcriptional/JJ
regulation/NN
of/IN
cytokine/NN
genes/NNS
by/IN
CD15/NN
engagement/NN
,/,
a/DT
CAT/NN
plasmid/NN
reporter/NN
construct/NN
containing/VBG
IL-1/NN
beta/NN
promoter/enhancer/NN
sequences/NNS
was/VBD
introduced/VBN
into/IN
MM6/NN
./.
=====
Subsequent/JJ
cross-linking/NN
of/IN
CD15/NN
increased/VBD
CAT/NN
activity/NN
./.
=====
CD15/NN
engagement/NN
by/IN
monoclonal/JJ
antibody/NN
also/RB
attenuated/VBD
IL-1/NN
beta/NN
transcript/NN
degradation/NN
,/,
demonstrating/VBG
that/IN
signaling/NN
via/IN
CD15/NN
also/RB
had/VBD
posttranscriptional/JJ
effects/NNS
./.
=====
Nuclear/JJ
extracts/NNS
of/IN
anti-CD15/JJ
cross-linked/JJ
cells/NNS
demonstrated/VBD
enhanced/VBN
levels/NNS
of/IN
the/DT
transcriptional/JJ
factor/NN
activator/NN
protein-1/NN
,/,
minimally/RB
changed/VBD
nuclear/JJ
factor-kappa/NN
B/NN
,/,
and/CC
did/VBD
not/RB
affect/VB
SV40/NN
promoter/NN
specific/JJ
protein-1/NN
./.
=====
We/PRP
conclude/VBP
that/IN
engagement/NN
of/IN
CD15/NN
on/IN
monocytes/NNS
results/VBZ
in/IN
monocyte/NN
activation/NN
./.
=====
In/IN
addition/NN
to/TO
its/PRP$
well-recognized/JJ
adhesive/JJ
role/NN
,/,
CD15/NN
may/MD
function/VB
as/IN
an/DT
important/JJ
signaling/VBG
molecule/NN
capable/JJ
of/IN
initiating/VBG
proinflammatory/JJ
events/NNS
in/IN
monocytes/NNS
that/WDT
come/VBP
into/IN
contact/NN
with/IN
activated/VBN
endothelium/NN
./.